Date de publication: 28 juin 2021
Promoteur – Intermédiaire Financier
EIB loan to finance the purchase of COVID-19 vaccines.
The proposed operation consists of an investment loan of up to USD 100 million to the Republic of Argentina, to part to finance the strengthening of the country's resilience and pandemic preparedness initiatives as included in the Argentinian national response plan to the current COVID-19 pandemic. In particular, the project will support the purchase of vaccines and the deployment of vaccination campaigns in alignment with a satisfactory country National Vaccine Deployment Plan (NVDP).
The project will be financed under the 2014-2020 External Lending Mandate or, to the extent possible, its successor Mandate.
- Santé - Santé humaine et action sociale
Garantie au titre du MPE
This operation is covered by the ELM Guarantee.
Montant BEI envisagé (montant approximatif)
USD 100 million (EUR 85 million)
Coût total (montant approximatif)
USD 1600 million (EUR 1353 million)
The Bank will require the Promoter to ensure that the implementation of the project will be done in accordance with the Bank's Environmental and Social Principles and Standards.
Passation des marchés
The Bank will require the Promoter to ensure that implementation of the project will be done in accordance with the Bank's Guide to Procurement.
Approuvé - 15/09/2021
Clause de non-responsabilité
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).